BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
wanbury limited stock

WANBURY LIMITED Share Price

305.75 -16.10 (-5.00%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: WANBURY

WANBURY LIMITED Share Price Update

As of the latest trading session, WANBURY LIMITED share price is currently at 305.75, which is down by -16.10 from its previous closing. Today, the stock has fluctuated between 305.75 and 320.00. Over the past year, WANBURY LIMITED has achieved a return of 352.09 %. In the last month alone, the return has been 11.56 %. Read More...

WANBURY LIMITED Performance

Day Range

Low305.75 High320.00
226.70

52 Week Range

Low 119.75 High 306.53
226.70

WANBURY LIMITED Share Price

14063

524212

WANBURY

img img img img
No Data Available

Open Price

319.80

Prev. Close

321.85

Volume (Shares)

31620.00

Total traded value

71.68

Upper Circuit

337.94

Lower Circuit

305.75

Note: The current prices & values are delayed, Login to your account for live updates.

WANBURY LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 999.97
PE Ratio (TTM) 28.26
Book Value / Share 8.49
Beta 0.68
ROE 0.00%
EPS (TTM) 8.17
Dividend Yield 0.00%
Net Profit Qtr (Cr) 1.04

WANBURY LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 131.11
Operating Expense 131.01
Net Profit 1.04
Net Profit Margin (%) 0.79
Earnings Per Share (EPS) 3274.55
EBITDA 11.91
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 139.41
Operating Expense 131.98
Net Profit 8.08
Net Profit Margin (%) 5.79
Earnings Per Share (EPS) 2.47
EBITDA 19.09
Effective Tax Rate (%) 3.23
Particulars DEC 2023 (Values in Cr)
Revenue 145.50
Operating Expense 135.93
Net Profit 10.27
Net Profit Margin (%) 7.05
Earnings Per Share (EPS) 3.14
EBITDA 21.84
Effective Tax Rate (%) -0.19
Particulars SEP 2023 (Values in Cr)
Revenue 144.46
Operating Expense 138.03
Net Profit 7.36
Net Profit Margin (%) 5.09
Earnings Per Share (EPS) 2.25
EBITDA 18.10
Effective Tax Rate (%) -2.50
Particulars JUN 2023 (Values in Cr)
Revenue 146.29
Operating Expense 141.91
Net Profit 4.69
Net Profit Margin (%) 3.20
Earnings Per Share (EPS) 1.43
EBITDA 13.96
Effective Tax Rate (%) 6.01
Particulars MAR 2024 (Values in Cr)
Revenue 575.65
Operating Expense 547.85
Net Profit 30.40
Net Profit Margin (%) 5.28
Earnings Per Share (EPS) 9.29
EBITDA 72.99
Effective Tax Rate (%) 1.23
Particulars MAR 2023 (Values in Cr)
Revenue 499.65
Operating Expense 510.25
Net Profit -10.40
Net Profit Margin (%) -2.08
Earnings Per Share (EPS) -3.18
EBITDA 23.48
Effective Tax Rate (%) -1.06
Particulars MAR 2022 (Values in Cr)
Revenue 511.19
Operating Expense 507.93
Net Profit 81.47
Net Profit Margin (%) 15.93
Earnings Per Share (EPS) 25.29
EBITDA 113.19
Effective Tax Rate (%) -0.43
Particulars MAR 2021 (Values in Cr)
Revenue 392.52
Operating Expense 407.32
Net Profit -12.61
Net Profit Margin (%) -3.21
Earnings Per Share (EPS) -5.04
EBITDA 20.41
Effective Tax Rate (%) -1.61
Particulars MAR 2020 (Values in Cr)
Revenue 367.45
Operating Expense 386.56
Net Profit 64.46
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 26.90
EBITDA 107.22
Effective Tax Rate (%) 0.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share -10.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 4.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share -7.27
ROE % 306.03
ROCE % 16.14
Total Debt to Total Equity 0.00
EBITDA Margin 7.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share -62.46
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 5.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share -57.39
ROE % 36.16
ROCE % 7.96
Total Debt to Total Equity 0.00
EBITDA Margin 6.67
Particulars MAR 2019 (Values in Cr)
Book Value / Share -88.23
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 6.35
Particulars MAR 2023 (Values in Cr)
Book Value / Share -2.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 4.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.57
ROE % 37.03
ROCE % 17.45
Total Debt to Total Equity 0.00
EBITDA Margin 7.26
Particulars MAR 2021 (Values in Cr)
Book Value / Share -52.23
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 5.20
Particulars MAR 2020 (Values in Cr)
Book Value / Share -47.14
ROE % 48.96
ROCE % 8.54
Total Debt to Total Equity 0.00
EBITDA Margin 6.64
Particulars MAR 2019 (Values in Cr)
Book Value / Share -77.40
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 6.35
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.93
Total Assets 303.87
Total Liabilities 303.87
Total Equity -32.81
Share Outstanding 32705498
Price to Book Ratio -16.51
Return on Assets (%) -3.42
Return on Capital (%) -33.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.31
Total Assets 352.54
Total Liabilities 352.54
Total Equity -23.41
Share Outstanding 32665498
Price to Book Ratio 149.12
Return on Assets (%) 23.10
Return on Capital (%) 186.85
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.70
Total Assets 289.17
Total Liabilities 289.17
Total Equity -156.24
Share Outstanding 25015117
Price to Book Ratio -1.59
Return on Assets (%) -4.35
Return on Capital (%) -301.65
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 16.69
Total Assets 278.69
Total Liabilities 278.69
Total Equity -143.45
Share Outstanding 24995117
Price to Book Ratio -0.39
Return on Assets (%) 23.13
Return on Capital (%) -339.49
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 5.24
Total Assets 286.04
Total Liabilities 286.04
Total Equity -209.27
Share Outstanding 23720117
Price to Book Ratio -0.28
Return on Assets (%) -8.68
Return on Capital (%) 2391.96
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.89
Total Assets 302.24
Total Liabilities 302.24
Total Equity -7.25
Share Outstanding 32705498
Price to Book Ratio -16.51
Return on Assets (%) -3.43
Return on Capital (%) -18.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.27
Total Assets 351.00
Total Liabilities 351.00
Total Equity 2.18
Share Outstanding 32665498
Price to Book Ratio 149.12
Return on Assets (%) 23.21
Return on Capital (%) 117.72
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.66
Total Assets 287.60
Total Liabilities 287.60
Total Equity -130.65
Share Outstanding 25015117
Price to Book Ratio -1.59
Return on Assets (%) -4.38
Return on Capital (%) -42.35
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 16.65
Total Assets 277.16
Total Liabilities 277.16
Total Equity -117.83
Share Outstanding 24995117
Price to Book Ratio -0.39
Return on Assets (%) 23.25
Return on Capital (%) 971.77
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 5.21
Total Assets 284.61
Total Liabilities 284.61
Total Equity -183.58
Share Outstanding 23720117
Price to Book Ratio -0.28
Return on Assets (%) -8.73
Return on Capital (%) -100.81
Particulars MAR 2023 (Values in Cr)
Net Income -10.28
Cash from Operations 19.97
Cash from Investing -8.83
Cash from Financing -31.99
Net change in Cash -21.03
Free Cash Flow 32.59
Particulars MAR 2022 (Values in Cr)
Net Income 81.12
Cash from Operations 40.68
Cash from Investing 0.58
Cash from Financing -28.58
Net change in Cash 12.52
Free Cash Flow 50.34
Particulars MAR 2021 (Values in Cr)
Net Income -12.40
Cash from Operations 17.81
Cash from Investing 8.04
Cash from Financing -17.38
Net change in Cash 7.34
Free Cash Flow 22.24
Particulars MAR 2020 (Values in Cr)
Net Income 64.67
Cash from Operations 44.16
Cash from Investing 63.66
Cash from Financing -107.87
Net change in Cash -0.07
Free Cash Flow 51.99
Particulars MAR 2019 (Values in Cr)
Net Income -24.98
Cash from Operations 29.79
Cash from Investing -3.07
Cash from Financing -26.78
Net change in Cash -0.12
Free Cash Flow 34.51
Particulars MAR 2023 (Values in Cr)
Net Income -10.28
Cash from Operations 19.97
Cash from Investing -8.83
Cash from Financing -31.99
Net change in Cash -21.03
Free Cash Flow 32.59
Particulars MAR 2022 (Values in Cr)
Net Income 81.12
Cash from Operations 40.68
Cash from Investing 0.58
Cash from Financing -28.58
Net change in Cash 12.52
Free Cash Flow 50.34
Particulars MAR 2021 (Values in Cr)
Net Income -12.40
Cash from Operations 17.81
Cash from Investing 8.04
Cash from Financing -17.38
Net change in Cash 7.34
Free Cash Flow 22.24
Particulars MAR 2020 (Values in Cr)
Net Income 64.67
Cash from Operations 44.15
Cash from Investing 63.66
Cash from Financing -107.87
Net change in Cash -0.08
Free Cash Flow 51.98
Particulars MAR 2019 (Values in Cr)
Net Income -24.98
Cash from Operations 29.79
Cash from Investing -3.07
Cash from Financing -26.78
Net change in Cash -0.12
Free Cash Flow 34.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
WANBURY LIMITED 230.85 28.05 27.16 755.93 51.74 / 254.00
BLISS GVS PHARMA LTD 125.00 12.83 1.35 1312.07 77.65 / 148.95
CIPLA LTD 1655.75 30.08 5.00 133711.73 1132.00 / 1660.50
FERMENTA BIOTECH LIMITED 309.80 0.00 3.15 911.77 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2745.40 60.38 26.16 46508.73 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
WANBURY LIMITED 230.85 28.26 27.16 755.93 51.74 / 254.00
AMRUTAJAN HEALTH LTD 819.40 55.63 8.21 2368.94 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6586.55 125.70 23.12 16466.38 4050.15 / 7550.00
BLISS GVS PHARMA LTD 125.00 13.44 1.32 1312.07 77.65 / 148.95
ABBOTT INDIA LIMITED 30176.60 51.76 17.33 64125.28 21907.45 / 30499.90

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 230.60
  • 26 Days 210.00
  • 10 Days 220.70
  • 50 Days 195.70
  • 12 Days 217.40
  • 100 Days 181.00
  • 20 Days 213.80
  • 200 Days 100.20
234.61
PIVOT
First Resistance 237.79
Second Resistance 242.86
Third Resistance 246.04
First Support 229.54
Second Support 226.36
Third Support 221.29
RSI 65.17
MACD 7.36
Commodity Channel Index (CCI) 111.99
ADX 24.95
Williams % R -28.89

Over 1 Month

down

11.56

Over 3 Months

down

55.21

Over 6 Months

down

45.24

Over 1 Year

down

352.09

Over 3 Years

down

41.31

Over 5 Years

down

81.21

WANBURY LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

WANBURY LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
59.98
Promoter Holdings
39.79
FII
0.22
DII
0.0
Promoter Shares(Pledge Percentage)
76.74
Name Category Shares Shares%
Expert Chemicals (india) Pvt Ltd Shareholding of Promoter and Promoter Group 1.0005561E7 30.56
Kingsbury Investments Inc. Shareholding of Promoter and Promoter Group 3024000.0 9.23
Authum Investment And Infrastructure Limited Public Shareholding 770000.0 2.35
Suresh Bhatia Public Shareholding 719230.0 2.2
Surbhi Investments And Trading Company Private Limited Public Shareholding 562399.0 1.72
Magnum Equifin Private Limited Public Shareholding 500100.0 1.53
East Eight Six Advisors Llp Public Shareholding 461538.0 1.41
Elizabeth Mathew Public Shareholding 371579.0 1.13
Milan Manharkant Ganatra Public Shareholding 353915.0 1.08
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs Public Shareholding 338465.0 1.03

WANBURY LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2010-07-29 1.0 Final 2010-08-02 Equity shares 2009-03-12 0.5 Final 2009-03-16 Equity shares 2007-09-13 2.0 Final 2007-09-17 Equity shares 2006-02-20 0.0 Interim 0001-01-01 Equity shares 2005-07-28 0.0 Final 2005-08-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Wanbury share result highlights

The Wanbury share price has experienced fluctuations following the company’s recent financial results. Wanbury reported moderate revenue growth, driven by strong demand in the pharmaceutical sector. However, profit margins were impacted by rising input costs and operational expenses. The company’s focus on expanding its product portfolio and enhancing its manufacturing capabilities contributed positively to overall revenue. Despite these efforts, net profit remained under pressure, reflecting the challenges faced in maintaining profitability. Nevertheless, Wanbury’s strategic initiatives in research and development have positioned it for future growth, keeping the Wanbury share price stable, with cautious optimism from investors about the company’s long-term performance.

Wanbury share annual reports

Wanbury’s annual reports provide a comprehensive overview of the company’s financial performance, which directly impacts the Wanbury share price. The reports highlight key metrics such as revenue growth, operational efficiency, and cost management. They also outline the company’s strategic initiatives, including investments in research and development, which are essential for future growth. Investors use these reports to assess Wanbury’s financial stability and long-term potential. The annual reports are crucial for understanding the company’s progress and the factors that drive the Wanbury share price, offering valuable insights into its operational and financial outlook.

Wanbury share dividend

Wanbury has not been a regular dividend-paying company in recent years due to its focus on reinvesting profits into business expansion and research initiatives. The company’s primary goal has been to strengthen its financial position and improve operational efficiencies. As a result, dividend payments have been limited, which may not attract income-focused investors. However, as Wanbury continues to stabilise its financial performance, future dividend payouts may become a possibility. This strategic reinvestment has helped support the long-term stability of the Wanbury share price.

About WANBURY LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by WANBURY LIMITED

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Wanbury Ltd?

Answer Field

The share price of Wanbury Ltd for NSE is ₹ 305.75 and for BSE is ₹ 305.95.

What is the Market Cap of Wanbury Ltd?

Answer Field

The market cap of Wanbury Ltd for NSE is ₹ 9,99.97 Cr. and for BSE is ₹ 10,00.62 Cr. as of now.

What is the 52 Week High and Low of Wanbury Ltd?

Answer Field

The 52 Week High and Low of Wanbury Ltd for NSE is ₹ 253.18 and ₹ 50.05 and for BSE is ₹ 254.00 and ₹ 51.74.

How to Buy Wanbury Ltd share?

Answer Field

You can trade in Wanbury Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Wanbury Ltd?

Answer Field

The 1 year returns on the stock has been 352.09%.

What is the Current Share Price of Wanbury Ltd?

Answer Field

Wanbury Ltd share price is for NSE ₹ 305.75 & for BSE ₹ 305.95 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Wanbury Ltd Share?

Answer Field

The market cap of Wanbury Ltd for NSE ₹ 9,99.97 & for BSE ₹ 10,00.62 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Wanbury Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Wanbury Ltd share is 28.26.

What is the PB ratio of Wanbury Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Wanbury Ltd share is 8.49.

How to Buy Wanbury Ltd Share?

Answer Field

You can trade in Wanbury Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Wanbury Ltd Share on Bajaj Broking App?

Answer Field

To buy Wanbury Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Wanbury Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs

Who is the CEO of Wanbury?

As of the latest available information, the CEO of Wanbury is Mr. Arvind Doshi. He is responsible for overseeing the company’s strategic direction and overall operations, which directly impact the Wanbury share price. His focus on expanding Wanbury’s product offerings and strengthening its position in the pharmaceutical sector plays a key role in driving the company’s financial performance and long-term growth.

 

When was Wanbury established?

Wanbury was established in 1990. Since its inception, the company has grown to become a prominent player in the pharmaceutical industry, specialising in active pharmaceutical ingredients and formulations. Over the years, Wanbury has expanded its operations, contributing to its strong market presence. This long-standing history has had a positive impact on the Wanbury share price, reflecting the company’s stability and growth potential.

 

What factors influence the Wanbury share price?

Several factors influence the Wanbury share price, including the company’s financial performance, revenue growth, and profitability margins. External factors such as regulatory changes, demand for pharmaceutical products, and market competition also play a significant role. Additionally, investor sentiment regarding Wanbury’s ability to manage costs, expand its product portfolio, and maintain profitability affects the share price movement.

 

Is Wanbury debt free?

Wanbury is not entirely debt-free, but it maintains a manageable level of debt. The company’s focus on effective debt management ensures that its financial obligations do not negatively impact its profitability. This controlled debt structure contributes to the overall stability of the Wanbury share price, as investors generally prefer companies with a balanced approach to managing liabilities and sustaining long-term growth.

 

How has the Wanbury share price performed over the past year?

Over the past year, the Wanbury share price has experienced moderate fluctuations, reflecting the company’s financial performance and market conditions. While the company has seen revenue growth, challenges related to rising input costs and operational expenses have impacted profitability. Despite these hurdles, the Wanbury share price has remained relatively stable, with investors maintaining cautious optimism about the company’s future growth potential.

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader